Renaissance Technologies »

Rigel Pharmaceuticals shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 145k 8.22

More positions owned by Renaissance Technologies

Novo-nordisk A S Adr (NVO)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Vertex Pharmaceuticals Incorporated (VRTX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Meta Platforms Cl A (META)
Airbnb Com Cl A (ABNB)
Broadcom (AVGO)
Tesla Motors (TSLA)
Sprouts Fmrs Mkt (SFM)
Franco-Nevada Corporation (FNV)
Apple (AAPL)
Gilead Sciences (GILD)
Exelixis (EXEL)

View all positions for Renaissance Technologies

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
Morgan Stanley
Soleus Capital Management
Vanguard Group
Susquehanna International
Acadian Asset Management
Assenagon Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
Jacobs Levy Equity Management
Renaissance Technologies
Healthcare Of Ontario Pension Plan Trust Fund
Ing Investment Management

View all funds holding Rigel Pharmaceuticals